First-line pembrolizumab for lung cancer in a Spanish real-world study.

被引：0

作者：

Burgos, Amparo

Calleja, Teresa

Ibanez, Cristina

Maria Valencia, Carmen

Orallo, Claudia

Carlos Titos, Jose

Conde, David

Diaz, Sacramento

Matilla, Belen

Lizeaga, Garbine

Sanchez, Carmen

Marin Pozo, Juan Francisco

Jimenez, Silvia

Jimenez, Inmaculada

Diez, Raul

Garrido, Margarita

Larrosa, Maria

Jose Martinez, Maria

Moreno, Estela

Garcia Campelo, Rosario

机构：

[1] Hosp Univ Dr Balmis Alicante ISABIAL, Alicante, Spain

[2] Hosp Univ La Coruna, La Coruna, Spain

[3] Catalan Inst Oncol Hosp, Oncol Pharm Dept, Lhospitalet De Llobregat, Spain

[4] Hosp Univ Marques de Valdecilla, Santander, Spain

[5] Hosp Univ Asturias, Oviedo, Spain

[6] Hosp Univ Morales Meseguer, Murcia, Spain

[7] Hosp Mar, Barcelona, Spain

[8] Hosp Clin Univ Virgen Arrixaca, Murcia, Spain

[9] Complejo Asistencial Univ Leon, Leon, Spain

[10] Hosp Univ Donostia, San Sebastian, Spain

[11] Hosp Univ Virgen de las Nieves, Granada, Spain

[12] Hosp Univ Jaen, Jaen, Spain

[13] Hosp Univ Salamanca, Salamanca, Spain

[14] Hosp Univ Elche, Elche, Spain

[15] Hosp Univ Getafe, Getafe, Spain

[16] Hosp Virgen Victoria, Malaga, Spain

[17] Hosp Univ Valle Hebron, Barcelona, Spain

[18] Hosp Univ Puerta Mar, Cadiz, Spain

[19] Hosp St Pau & Santa Creu Barcelona, Barcelona, Spain

[20] Hosp Univ A Coruna, La Coruna, Spain

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e23268

引用

页数：1

共 50 条

[41] Response to the Letter re: Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed
Leonetti, Alessandro
Perrone, Fabiana
Puntoni, Matteo
Maglietta, Giuseppe
Caminiti, Caterina
Tiseo, Marcello
EUROPEAN JOURNAL OF CANCER, 2024, 212
[42] Safety of pembrolizumab in patients with non-small cell lung cancer: a real-world study
Thakrar, D. B.
Essang, B.
Echlin, A.
Murdock, C.
Lind, M. J.
LUNG CANCER, 2019, 127 : S40 - S41
[43] Pembrolizumab for the first-line treatment of non-small cell lung cancer
Ninomiya, Kiichiro
Hotta, Katsuyuki
EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (10) : 1015 - 1021
[44] Real-world evidence for immunotherapy in the first line setting in small cell lung cancer
Sagie, Shira
Maixner, Nitzan
Stemmer, Amos
Lobachov, Anastasiya
Bar, Jair
Urban, Damien
LUNG CANCER, 2022, 172 : 136 - 141
[45] Real-world outcomes of first-line chemotherapy for unresectable stage III and IV bladder cancer
Daan J. Reesink
Harm H. E. van Melick
Paul B. van der Nat
Maartje Los
Simon Horenblas
Ewoudt M. W. van de Garde
World Journal of Urology, 2023, 41 : 1551 - 1562
[46] Real-world outcomes of first-line chemotherapy for unresectable stage III and IV bladder cancer
Reesink, Daan
van Melick, Harm H. E.
van der Nat, Paul
Los, Maartje
Horenblas, Simon
van de Garde, Ewoudt M. W.
Santeon MIBC Study Grp
WORLD JOURNAL OF UROLOGY, 2023, 41 (06) : 1551 - 1562
[47] Real-world outcomes of first-line maintenance with niraparib or bevacizumab in advanced ovarian cancer.
Vasudevan, Anupama
English, Sandy
Gart, Mike
Oladipo, Taofikat
Hartman, John
Iadeluca, Laura L.
Kudrik, Fred J.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[48] Diversity of first-line palliative systemic treatments for esophagogastric cancer patients with synchronous metastases: A real world evidence study.
Dijksterhuis, Willemieke P. M.
van Oijen, Martijn G. H.
Verhoeven, Rob H. A.
Van Laarhoven, Hanneke W. M.
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[49] Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck Cancer
Wagner, Sandro. M.
Magnes, Teresa
Melchardt, Thomas
Kiem, Dominik
Weiss, Lukas
Neureiter, Daniel
Wagner, Christina
Aretin, Marie-Bernadette
Nemec, Stefan
Gamerith, Gabriele
Pall, Georg
Greil, Richard
Fuereder, Thorsten
ANTICANCER RESEARCH, 2023, 43 (03) : 1273 - 1282
[50] Optimal first-line chemotherapy for the elderly with metastatic colorectal cancer, based on the real-world data
Sugimura, N.
Shimura, T.
Fukusada, S.
Tanaka, M.
Kataoka, H.
ANNALS OF ONCOLOGY, 2024, 35 : S1446 - S1446

← 1 2 3 4 5 →